XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Changes and Error Corrections [Abstract]  
Schedule of Impact on Financial Statements

The effect of the Restatement described above on the accompanying consolidated statements of operations for the three months ended March 31, 2019 and 2018 is as follows:

 

   Three Months Ended March 31, 2018 
   As Previously   Revenue       Income   As 
   Reported   Recognition   Other   Taxes   Restated 
Revenue  $18,191,623   $(3,201,672)  $   $   $14,989,951 
Cost of sales   14,141,755    27,862    (280,143)       13,889,474 
Gross profit   4,049,868    (3,229,534)   280,143        1,100,477 
Selling, general and administrative expenses   2,049,840        45,086        2,094,926 
Income (loss) from operations   2,000,028    (3,229,534)   235,057        (994,449)
Interest expense   447,263                447,263 
Income (loss) before provision for (benefit from) income taxes   1,552,765    (3,229,534)   235,057        (1,441,712)
Provision for (benefit from) income taxes   296,000            (294,805)   1,195 
Net income (loss)   1,256,765    (3,229,534)   235,057   294,805    (1,442,907)
Other comprehensive loss net of tax–Change in unrealized loss interest rate swap on int on interest rate swap   (5,800)               (5,800)
Comprehensive income (loss)  $1,250,965   $(3,229,534)  $235,057   $294,805   $(1,448,707)
                          
Income (loss) per common share – basic  $0.14                  $(0.16)
Income (loss) per common share – diluted  $0.14                  $(0.16)
                          
Shares used in computing earnings (loss) per common share:                         
Basic   8,888,179                   8,888,179 
Diluted   8,940,385                   8,888,179 

 

   Three Months Ended March 31, 2019 
   As Previously
Reported
   Revenue
Recognition
   Other   Income
Taxes
   As Restated 
Revenue  $25,583,531  $(3,595,147)  $   $   $21,988,384 
Cost of sales   20,167,721    (662,753)           19,504,968 
Gross profit   5,415,810    (2,932,394)           2,483,416 
Selling, general and administrative expenses   2,806,443        99,243        2,905,686 
Income (loss) from operations   2,609,367    (2,932,394)   (99,243)       (422,270)
Interest expense   510,769                510,769 
Income (loss) before provision for (benefit from) income taxes   2,098,598    (2,932,394)   (99,243)       (933,039)

Provision for (benefit from) income taxes

   440,000            (438,323)   1,677 
Net income (loss)  $1,658,598  $(2,932,394)  $(99,243)  $438,323   $(934,716)
                          
Income per common share – basic  $0.14                  $(0.08)
Income per common share – diluted  $0.14                  $(0.08)
                          
Shares used in computing earnings per common share:                         
Basic   11,736,305                   11,736,305 
Diluted   11,792,818                   11,736,305 

  

The effect of the Restatement described above on the accompanying consolidated balance sheets as of March 31, 2019 and December 31, 2018 is as follows:

                     
   As of March 31, 2019 
   As Previously Reported   Revenue
Recognition
   Other   Income
Taxes
   As Restated 
ASSETS                    
Current Assets:                         
Cash  $617,161   $   $   $   $617,161 
Restricted cash   2,000,000                2,000,000 
Accounts receivable, net   6,583,155                6,583,155 
Contract assets   120,749,918    (100,971,165)           19,778,753 
Inventory   11,090,995        (350,386)       10,740,609 
Refundable income taxes   435,000            (97)   434,903 
Prepaid expenses and other current assets   1,205,297                1,205,297 
Total Current Assets   142,681,526    (100,971,165)   (350,386)   (97)   41,359,878 
                          
Operating lease right-of-use assets   4,927,810                4,927,810 
Property and equipment, net   3,533,038                3,533,038 
Refundable income taxes               434,903    434,903 
Deferred income taxes   486,664            (486,664)    
Other assets   229,552                229,552 
Total Assets  $151,858,590   $(100,971,165)  $(350,386)  $(51,858)  $50,485,181 
                          
Liabilities and Shareholders' Equity (Deficit)                         
Current Liabilities:                         
Accounts payable  $12,364,039   $   $   $   $12,364,039 
Accrued expenses   1,089,803                1,089,803 
Contract liabilities   3,279,843    (3,190)           3,276,653 
Loss reserve   216,606    2,820,076            3,036,682 
Current portion of long-term debt   2,506,099                2,506,099 
Operating lease liabilities   1,593,243                1,593,243 
Income taxes payable   253,798            (211,677)   42,121 
Total Current Liabilities   21,303,431    2,816,886        (211,677)   23,908,640 
                          
Line of credit   23,738,685                23,738,685 
Long-term operating lease liabilities   3,837,678                3,837,678 
Long-term debt, net of current portion   3,601,883                3,601,883 
Deferred income taxes   4,028,553            (4,028,553)    
Total Liabilities   56,510,230    2,816,886        (4,240,230)   55,086,886 
                          
Shareholders' Equity (Deficit):                         
Common stock   11,736                11,736 
Additional paid-in capital   70,917,811                70,917,811 
Retained earnings (accumulated deficit)   24,418,813    (103,788,051)   (350,386)   4,188,372    (75,531,252)
Total Shareholders’ Equity (Deficit)   95,348,360    (103,788,051)   (350,386)   4,188,372    (4,601,705)
                          
Total Liabilities and Shareholders’
Equity (Deficit)
  $151,858,590   $(100,971,165)  $(350,386)  $(51,858)  $50,485,181 

 

 

   As of December 31, 2018 
   As Previously
Reported
   Revenue
Recognition
   Other   Income
Taxes
   As Restated 
ASSETS                    
Current Assets:                         
Cash  $4,128,142   $   $   $   $4,128,142 
Restricted cash   2,000,000                2,000,000 
Accounts receivable, net   8,623,329        99,242        8,722,571 
Contract assets   113,333,491    (95,744,625)           17,588,866 
Inventory   9,711,997        (350,386)       9,361,611 
Refundable income taxes   435,000            (97)   434,903 
Prepaid expenses and other current assets   1,972,630                1,972,630 
Total Current Assets   140,204,589    (95,744,625)   (251,144)   (97)   44,208,723 
                          
Property and equipment, net   2,545,192                2,545,192 
Refundable income taxes   435,000            (97)   434,903 
Deferred income taxes   279,318            (279,318)    
Other assets   249,575                249,575 
Total Assets  $143,713,674   $(95,744,625)  $(251,144)  $(279,512)  $47,438,393 
                          
Liabilities and Shareholders' Equity (Deficit)                         
Current Liabilities:                         
Accounts payable  $9,902,481   $   $   $   $9,902,481 
Accrued expenses   1,558,160                1,558,160 
Contract liabilities   3,588,500    1,664,079            5,252,579 
Loss reserve   216,606    3,446,952            3,663,558 
Current portion of long-term debt   2,434,981                2,434,981 
Income taxes payable   115,000            (1,008)   113,992 
Total Current Liabilities   17,815,728    5,111,031        (1,008)   22,925,751 
                          
Line of credit   24,038,685                24,038,685 
Long-term debt, net of current portion   3,876,238                3,876,238 
Deferred income taxes   4,028,553            (4,028,553)    
Other liabilities   531,124                531,124 
Total Liabilities   50,290,328    5,111,031        (4,029,561)   51,371,798 
                          
Shareholders’ Equity (Deficit):                         
Common stock   11,718                11,718 
Additional paid-in capital   70,651,413                70,651,413 
Retained earnings (accumulated deficit)   22,760,215    (100,855,656)   (251,144)   3,750,049    (74,596,536)
Total Shareholders’ Equity (Deficit)   93,423,346    (100,855,656)   (251,144)   3,750,049    (3,933,405)
                          
Total Liabilities and Shareholders' Equity(Deficit)  $143,713,674   $(95,744,625)  $(251,144)  $(279,512)  $47,438,393 

 

The following table presents the impact of the Restatement on the Company’s shareholders’ equity (deficit) as of January 1, 2018:

  

   Common
Stock
   Additional
Paid-in
Capital
   Retained
Earnings
(Accumulated
Deficit)
   Accumulated
Other
Comprehensive
Loss
   Total
Shareholders’
Equity (Deficit)
 
Balance, January 1, 2018                    
(As previously reported)  $8,864   $53,770,617   $20,548,652   $(14,800)  $74,313,333 
Adjustments:                         
Revenue recognition           (86,621,280)       (86,621,280)
Other           (280,143)       (280,143)
Income taxes           (697,012)       (697,012)
                          
Cumulative restatement adjustments           (87,598,435)       (87,598,435)
Balance, January 1, 2018                         

(As Restated)

  $8,864   $53,770,617   $(67,049,783)  $(14,800)  $(13,285,102)

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the three months ended March 31, 2019 is as follows:

 

   Three Months Ended March 31, 2019 
   As Previously
Reported
   Restatement
Adjustments
   As Restated 
Cash flows from operating activities:               
Net income (loss)  $1,658,598   $(2,593,314)  $(934,716)
Adjustments to reconcile net income (loss) to net cash used in operating activities:               
Depreciation and amortization   209,261        209,261 
Amortization of debt issuance cost   20,024    16,929    36,953 
Cash expended in excess of rent expense   (28,012)       (28,012)
Stock-based compensation   330,787        330,787 
Deferred income taxes   (207,346)   207,346     
Changes in operating assets and liabilities:               
Decrease in accounts receivable   2,040,174    99,243    2,139,417 
Increase in contract assets   (7,416,427)   5,226,539    (2,189,888)
Increase in inventory   (1,378,998)       (1,378,998)
Decrease in refundable income taxes   435,000    (435,000)    
Decrease in prepaid expenses and other current assets   558,845    (17,054)   541,791 
Increase in accounts payable and accrued expenses   1,993,200        1,993,200 
Decrease in contract liabilities   (686,782)   (1,667,144)   (2,353,926)
Decrease in loss reserve       (626,876)   (626,876)
Increase (decrease) in income taxes payable   138,798    (210,669)   (71,871)
Net cash used in operating activities   (2,332,878)       (2,332,878)
Cash flows from investing activities:               
Purchase of property and equipment   (210,695)       (210,695)
Net cash used in investing activities   (210,695)       (210,695)
Cash flows from financing activities:               
Payments of long-term debt   (603,037)       (603,037)
Payments of line of credit   (300,000)       (300,000)
Stock offering costs paid   (64,371)       (64,371)
Net cash used in financing activities   (967,408)       (967,408)
Net decrease in cash and restricted cash   (3,510,981)       (3,510,981)
Cash and restricted cash at beginning of period   6,128,142        6,128,142 
Cash and restricted cash at end of period  $2,617,161   $   $2,617,161 
Supplemental disclosures of cash flow information:               
Cash paid during the period for interest  $551,635   $   $551,635 
Cash paid during the period for income taxes  $90,202   $   $90,202 
Supplemental schedule of noncash investing and financing activities:               
Equipment acquired under financing lease  $399,800   $   $399,800 

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the three months ended March 31, 2018 is as follows:

 

   Three Months Ended March 31, 2018 
   As Previously
Reported
   Restatement
Adjustments
   As Restated 
Cash flows from operating activities:               
Net income (loss)  $1,256,765   $(2,699,672)  $(1,442,907)
Adjustments to reconcile net income (loss) to net cash used in operating activities:               
Depreciation and amortization   153,297        153,297 
Amortization of debt issuance cost   21,392        21,392 
Cash expended in excess of rent expense   (17,692)       (17,692)
Stock-based compensation   303,940    (93,912)   210,028 
Bad debt expense       150,000    150,000 
Common stock issued as employee compensation   45,913        45,913 
Deferred income taxes   405,000    (405,000)    
Changes in operating assets and liabilities:               
Decrease in accounts receivable   1,395,407    (150,000)   1,245,407 
(Increase) decrease in contract assets   (2,865,025)   3,260,082    395,057 
Increase in inventory   (49,100)       (49,100)
Decrease in prepaid expenses and other current assets   98,683        98,683 
Decrease in accounts payable and accrued expenses   (3,247,776)   (141,146)   (3,388,922)
Increase in contract liabilities   35,198    (3,091)   32,107 
Decrease in loss reserve       (27,456)   (27,456)
Increase (decrease) in income taxes payable   (109,327)   110,195    868 
Net cash used in operating activities   (2,573,325)       (2,573,325)
Cash flows from investing activities:               
Purchase of property and equipment   (156,006)       (156,006)
Net cash used in investing activities   (156,006)       (156,006)
Cash flows from financing activities:               
Payments of long-term debt   (418,306)       (418,306)
Proceeds from line of credit   2,000,000        2,000,000 
Net cash used in financing activities   1,581,694        1,581,694 
Net decrease in cash and restricted cash   (1,147,637)       (1,147,637)
Cash and restricted cash at beginning of period   1,430,877        1,430,877 
Cash and restricted cash at end of period  $283,240   $   $283,240 
Supplemental disclosures of cash flow information:               
Cash paid during the period for interest  $429,614   $   $429,614